Clinical Trial Update: Predictors of Recurrent Stroke in the PROGRESS Study

View source ↗

Summary

This update analyzes factors that predict recurrent stroke in the PROGRESS trial, exploring which patient characteristics influenced stroke recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension
• Stroke

Drugs mentioned

• Indapamide (Indapamide)
• perindopril (perindopril)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Cerebrovascular Accident | Status: COMPLETED